Live from the NIH registry
Studies recruiting near Manchester right now
Top 25 of 89 recruiting studies, sorted by proximity — each links to its official registry page
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
University of New Hampshire — Durham, New Hampshire (28.1 mi)
· Sponsor: Tufts University
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Inflammatory Bowel Syndrome
N/A
Observational 220 participants sought
ALPCO — Salem, New Hampshire (18.3 mi)
· Sponsor: American Laboratory Products Company
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome, Respiratory Failure
Phase 3
Interventional 1,100 participants sought
Lowell General Hospital — Lowell, Massachusetts (25.1 mi)
· Sponsor: Beth Israel Deaconess Medical Center
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
N/A
Observational 538 participants sought
Lowell General Hosptial — Lowell, Massachusetts (25.1 mi)
· Sponsor: PrECOG, LLC.
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.
Hypothyroidism
Phase 3
Interventional 466 participants sought
ActivMed Practices and Research — Methuen, Massachusetts (22.0 mi)
· Sponsor: Neuvosyn Laboratories, LLC
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
Insulin Resistance, Impaired Glucose Tolerance
N/A
Interventional 45 participants sought
University of New Hampshire Cardiometabolic Research Laboratory — Durham, New Hampshire (28.1 mi)
· Sponsor: University of New Hampshire
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
Cardiac Arrythmias
N/A
Observational 100 participants sought
Catholic Medical Center — Manchester, New Hampshire (0.9 mi)
· Sponsor: Boston Scientific Corporation
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
ActivMed Practices and Research — Methuen, Massachusetts (22.0 mi)
· Sponsor: Eli Lilly and Company
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi)
· Sponsor: NRG Oncology
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Dartmouth Cancer Center - Manchester/ DCC Manchester — Manchester, New Hampshire (0.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC)
Phase 3
Interventional 1,040 participants sought
Dana Farber-Merrimack Valley — Methuen, Massachusetts (22.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Manchester, New Hampshire (0.9 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Allergic Conjunctivitis
Phase 3
Interventional 350 participants sought
Andover Eye Associates — Andover, Massachusetts (27.4 mi)
· Sponsor: Regeneron Pharmaceuticals
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
Anxiety Disorders, Depression Disorders
N/A
Interventional 2,448 participants sought
Dartmouth Hitchcock Manchester Family Practice — Manchester, New Hampshire (0.9 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Southern New Hampshire Diabetes and Endocrinology /ID# 257841 — Nashua, New Hampshire (15.2 mi)
· Sponsor: AbbVie
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Chronic Granulomatous Disease (CGD)
N/A
Observational 60 participants sought
Home-based telemedicine — Concord, New Hampshire (16.1 mi)
· Sponsor: Ensoma
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Lowell General Hospital — Lowell, Massachusetts (25.1 mi)
· Sponsor: NRG Oncology
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Extensive Stage Lung Small Cell Carcinoma
Phase 2, Phase 3
Interventional 138 participants sought
Lowell General Hospital — Lowell, Massachusetts (25.1 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi)
· Sponsor: NRG Oncology
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Manchester, New Hampshire (0.9 mi)
· Sponsor: AstraZeneca
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Dana Farber-Merrimack Valley — Methuen, Massachusetts (22.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
CCM OPEN HF Registry
Heart Failure
N/A
Observational 5,500 participants sought
Cardiovascular Specialists of New England Research Foundation — Londonderry, New Hampshire (9.0 mi)
· Sponsor: Impulse Dynamics
3D Printed Orthosis for Wrist Instability for Ehlers-Danlos Syndrome Patient
Ehlers-Danlos Syndrome Hypermobility Type (hEDS)
N/A
Observational 4 participants sought
UMass Lowell, Expanded Media Fabrication Lab — Lowell, Massachusetts (25.1 mi)
· Sponsor: ELewis
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Breast Cancer, NOS, CNS Primary Tumor, NOS
N/A
Interventional 400 participants sought
Lowell General Hospital — Lowell, Massachusetts (25.1 mi)
· Sponsor: Eastern Cooperative Oncology Group